MedPath

DAVID DICKENS

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Early Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Early Phase 1
1 (100.0%)

Gemcitabine With Ascorbate Including Adolescents

Early Phase 1
Withdrawn
Conditions
Metastatic Bone Sarcoma
Bone Sarcoma
Unresectable Soft Tissue Sarcoma
Unresectable Bone Sarcoma
Soft Tissue Sarcoma
Metastatic Soft-tissue Sarcoma
Interventions
First Posted Date
2021-05-07
Last Posted Date
2023-02-22
Lead Sponsor
David Dickens
Registration Number
NCT04877587
Locations
🇺🇸

University of Iowa Hospitals & Clinics, Iowa City, Iowa, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.